758 related articles for article (PubMed ID: 26044583)
1. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction.
Ye Y; Birnbaum GD; Perez-Polo JR; Nanhwan MK; Nylander S; Birnbaum Y
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1805-14. PubMed ID: 26044583
[TBL] [Abstract][Full Text] [Related]
2. Chronic treatment with ticagrelor limits myocardial infarct size: an adenosine and cyclooxygenase-2-dependent effect.
Nanhwan MK; Ling S; Kodakandla M; Nylander S; Ye Y; Birnbaum Y
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2078-85. PubMed ID: 25012137
[TBL] [Abstract][Full Text] [Related]
3. Ticagrelor Improves Remodeling, Reduces Apoptosis, Inflammation and Fibrosis and Increases the Number of Progenitor Stem Cells After Myocardial Infarction in a Rat Model of Ischemia Reperfusion.
Birnbaum Y; Tran D; Chen H; Nylander S; Sampaio LC; Ye Y
Cell Physiol Biochem; 2019; 53(6):961-981. PubMed ID: 31820856
[TBL] [Abstract][Full Text] [Related]
4. Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y
Audia JP; Yang XM; Crockett ES; Housley N; Haq EU; O'Donnell K; Cohen MV; Downey JM; Alvarez DF
Basic Res Cardiol; 2018 Jul; 113(5):32. PubMed ID: 29992382
[TBL] [Abstract][Full Text] [Related]
5. Protective Effects of Ticagrelor on Myocardial Injury After Infarction.
Vilahur G; Gutiérrez M; Casani L; Varela L; Capdevila A; Pons-Lladó G; Carreras F; Carlsson L; Hidalgo A; Badimon L
Circulation; 2016 Nov; 134(22):1708-1719. PubMed ID: 27789556
[TBL] [Abstract][Full Text] [Related]
6. P2Y12 antagonists and cardiac repair post-myocardial infarction: global and regional heart function analysis and molecular assessments in pigs.
Vilahur G; Gutiérrez M; Casani L; Lambert C; Mendieta G; Ben-Aicha S; Capdevila A; Pons-Lladó G; Carreras F; Carlsson L; Hidalgo A; Badimon L
Cardiovasc Res; 2018 Dec; 114(14):1860-1870. PubMed ID: 30124783
[TBL] [Abstract][Full Text] [Related]
7. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
[TBL] [Abstract][Full Text] [Related]
8. Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine.
Birnbaum Y; Birnbaum GD; Birnbaum I; Nylander S; Ye Y
Cardiovasc Drugs Ther; 2016 Dec; 30(6):539-550. PubMed ID: 27830382
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model.
Wang K; Zhou X; Huang Y; Khalil M; Wiktor D; van Giezen JJ; Penn MS
Thromb Haemost; 2010 Sep; 104(3):609-17. PubMed ID: 20694285
[TBL] [Abstract][Full Text] [Related]
10. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
[TBL] [Abstract][Full Text] [Related]
11. Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult.
Huang C; Cui Y; Ji L; Zhang W; Li R; Ma L; Xing W; Zhou H; Chen B; Yu J; Zhang H
Pharm Biol; 2013 Apr; 51(4):463-73. PubMed ID: 23336403
[TBL] [Abstract][Full Text] [Related]
12. Platelet P2Y₁₂ blockers confer direct postconditioning-like protection in reperfused rabbit hearts.
Yang XM; Liu Y; Cui L; Yang X; Liu Y; Tandon N; Kambayashi J; Downey JM; Cohen MV
J Cardiovasc Pharmacol Ther; 2013 May; 18(3):251-62. PubMed ID: 23233653
[TBL] [Abstract][Full Text] [Related]
13. Cordycepin, 3'-deoxyadenosine, prevents rat hearts from ischemia/reperfusion injury via activation of Akt/GSK-3β/p70S6K signaling pathway and HO-1 expression.
Park ES; Kang DH; Yang MK; Kang JC; Jang YC; Park JS; Kim SK; Shin HS
Cardiovasc Toxicol; 2014 Mar; 14(1):1-9. PubMed ID: 24178833
[TBL] [Abstract][Full Text] [Related]
14. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
Strande JL; Hsu A; Su J; Fu X; Gross GJ; Baker JE
Basic Res Cardiol; 2007 Jul; 102(4):350-8. PubMed ID: 17468933
[TBL] [Abstract][Full Text] [Related]
15. Impairment of cardiac function and remodeling induced by myocardial infarction in rats are attenuated by the nonpeptide angiotensin-(1-7) analog AVE 0991.
Zeng WT; Chen WY; Leng XY; Tang LL; Sun XT; Li CL; Dai G
Cardiovasc Ther; 2012 Jun; 30(3):152-61. PubMed ID: 21167013
[TBL] [Abstract][Full Text] [Related]
16. Ticagrelor Does Not Protect Isolated Rat Hearts, Thus Clouding Its Proposed Cardioprotective Role Through ENT 1 in Heart Tissue.
Yang XM; Gadde S; Audia JP; Alvarez DF; Downey JM; Cohen MV
J Cardiovasc Pharmacol Ther; 2019 Jul; 24(4):371-376. PubMed ID: 30744423
[TBL] [Abstract][Full Text] [Related]
17. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
[TBL] [Abstract][Full Text] [Related]
18. Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart.
Faghihi M; Mirershadi F; Dehpour AR; Bazargan M
Eur J Pharmacol; 2008 Nov; 597(1-3):57-63. PubMed ID: 18789320
[TBL] [Abstract][Full Text] [Related]
19. Cytoprotective effect of bis(1-oxy-2-pyridinethiolato)oxovanadiun(IV) on myocardial ischemia/reperfusion injury elicits inhibition of Fas ligand and Bim expression and elevation of FLIP expression.
Bhuiyan MS; Shibuya M; Shioda N; Moriguchi S; Kasahara J; Iwabuchi Y; Fukunaga K
Eur J Pharmacol; 2007 Oct; 571(2-3):180-8. PubMed ID: 17658509
[TBL] [Abstract][Full Text] [Related]
20. Modulation of myocardial injury and collagen deposition following ischaemia-reperfusion by linagliptin and liraglutide, and both together.
Wang X; Ding Z; Yang F; Dai Y; Chen P; Theus S; Singh S; Budhiraja M; Mehta JL
Clin Sci (Lond); 2016 Aug; 130(15):1353-62. PubMed ID: 27129181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
